In the interview, concepts such as what gene therapy is, what is it for, how many different types of gene therapy there are, what we do in VIVEbiotech and how VIVEbiotech addresses gene therapy were reviewed, as well as many other more philosophical and/or ethical concepts such as transhumanization or “children on demand”.
Canal Europa is an open space for the circulation of knowledge. Artists, writers, scientists, economists, medical doctors or politicians, among other disciplines, meet here to offer us their knowledge, their reflections, the routes and the goals of their creativity.
VIVEbiotech is a biotechnology company that manufactures lentiviral vectors for human gene therapy clinical trials, and that also develops proprietary technologies such as Lentisoma.
You can listen to the full interview here.